This information is intended for US patients and caregivers to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended to promote the use of our products, nor to provide medical advice.

Can SPRAVATO Cause Sedation, Dissociation, and Respiratory Depression?

Last Updated: 11/11/2026

summary

Here is a passage from the SPRAVATO MEDICATION GUIDE which may be helpful to address your question:

Can SPRAVATO cause sedation, dissociation, and respiratory depression?

SPRAVATO may cause serious side effects, including sedation, dissociation, and respiratory depression1:

  • SPRAVATO may cause:
    • sleepiness (sedation) or fainting. Tell your healthcare provider right away if you feel like you cannot stay awake or if you feel like you are going to pass out.
    • a feeling of being disconnected from yourself, your thoughts, your feelings, and space and time (dissociation).
    • difficulty or stopped breathing (respiratory depression or respiratory arrest).
  • Your healthcare provider must monitor you for at least 2 hours after taking SPRAVATO. Your healthcare provider will decide when you are ready to leave the healthcare setting.

SPRAVATO Risk Evaluation and Mitigation Strategy (REMS)

  • Because of the risks for sedation, dissociation, respiratory depression, abuse and misuse, SPRAVATO is only available through a restricted program called the SPRAVATO Risk Evaluation and Mitigation Strategy (REMS). SPRAVATO can only be administered at healthcare settings certified in the SPRAVATO REMS program. Patients treated in outpatient healthcare settings (such as medical offices and clinics) must be enrolled in the program.1

What should I avoid while taking SPRAVATO?

  • Do not drive, operate machinery, or do activities that require you to be fully alert and coordinated after taking SPRAVATO. Do not take part in these activities until the next day following a restful sleep.1

additional information

This information is provided ONLY in response to your request and is not intended as medical advice, to promote the use of our product, or suggest use in any manner other than as described in the PRESCRIBING INFORMATION. All decisions regarding your medical treatment should be made with your healthcare professional(s). Please contact your healthcare professional(s) to discuss the information in this response.

Please refer to the attached full PRESCRIBING INFORMATION and the MEDICATION GUIDE for SPRAVATO.1

References

1 SPRAVATO (esketamine) nasal spray [Prescribing Information]. Titusville, NJ: Janssen Pharmaceuticals, Inc; https://www.jnjlabels.com/package-insert/product-monograph/prescribing-information/SPRAVATO-pi.pdf
J&J Medical Connect

Connect with us

  • Products

Would you like to clear and leave your conversation? Message history will be lost.